0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gold Nanoparticle Market by Application, Type, Size, Surface Functionality, End User, Synthesis Method - Global Forecast to 2030- Product Image
Gold Nanoparticle Market by Application, Type, Size, Surface Functionality, End User, Synthesis Method - Global Forecast to 2030- Product Image
Sale

Gold Nanoparticle Market by Application, Type, Size, Surface Functionality, End User, Synthesis Method - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904568
UP TO EUR$697USDGBP OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Gold Nanoparticle Market grew from USD 806.31 million in 2024 to USD 888.15 million in 2025. It is expected to continue growing at a CAGR of 10.31%, reaching USD 1.45 billion by 2030.

Illuminating the Promise of Gold Nanoparticles in Modern Science

Gold nanoparticles have rapidly emerged as a cornerstone of modern nanotechnology, offering unparalleled opportunities to revolutionize diagnostics, therapeutics, and material sciences. Their unique physicochemical properties-size-dependent optical resonance, high surface-to-volume ratio, and tunable surface chemistry-have positioned them at the forefront of cutting-edge research and commercial applications. From enabling ultra-sensitive biosensing platforms to serving as precision carriers in targeted drug delivery, these nanoscale gold constructs are redefining established paradigms across multiple industries.

This executive summary synthesizes the critical developments, market dynamics, and strategic considerations shaping the global gold nanoparticle ecosystem. It presents an insightful overview of transformative innovations, regulatory shifts, and external pressures such as the United States tariffs enacted in 2025. The objective is to furnish decision-makers with a clear understanding of segmentation drivers, regional nuances, and competitive landscapes. By distilling complex data into actionable intelligence, this summary aims to guide stakeholders in research organizations, biotech enterprises, and healthcare institutions toward informed strategic planning and sustainable growth.

Emergence of Pivotal Innovations Shaping the Gold Nanoparticle Market

The gold nanoparticle sector has undergone profound shifts driven by breakthroughs in synthesis and surface engineering. Recent advances in green synthesis methodologies have reduced environmental impact and improved batch-to-batch consistency, while innovations in seed-mediated growth have unlocked precise control over particle morphology. Concurrently, progress in antibody conjugation and polymer coatings has enhanced biocompatibility and targeted functionality, broadening the scope of clinical translation and regulatory approval.

Technological convergence has further accelerated market evolution. Integration of artificial intelligence and machine learning in nanoparticle design has optimized functionalization protocols, resulting in more efficient drug delivery vectors and highly sensitive diagnostic assays. In parallel, the rise of multimodal imaging-combining electron microscopy with optical and photoacoustic techniques-has deepened our understanding of in vivo behavior, expediting path from bench to bedside. These cumulative innovations have not only diversified application pipelines but also redefined competitive benchmarks, setting the stage for next-generation solutions that marry precision with scalability.

Assessing the Ripple Effects of 2025 US Tariffs on Gold Nanoparticle Supply Chains

The 2025 implementation of U.S. tariffs on key raw materials and imported nanoscale components has introduced a new layer of complexity across the global supply chain. Manufacturers reliant on overseas procurement have encountered elevated costs for gold salts and specialized ligands, prompting many to explore domestic sourcing or vertical integration. This shift has induced a ripple effect, with downstream producers adjusting pricing strategies to maintain margins and remain competitive in research and clinical markets.

In response, several stakeholders have adopted strategic stockpiling practices and diversified supplier portfolios to mitigate exposure to tariff-related disruptions. Collaborative frameworks between material suppliers and biotech firms have emerged, designed to share cost burdens and streamline logistics. At the same time, an increase in regional manufacturing hubs has been observed, reflecting a broader trend toward reshoring critical nanomaterial production. While these adaptations have tempered short-term volatility, they underscore the need for proactive risk management and agile supply-chain architectures in an era of evolving trade policies.

Unpacking Diverse Market Segments Driving Growth Dynamics

The gold nanoparticle market encompasses a rich tapestry of applications, each driving distinct demand trajectories. Within diagnostics, biosensing platforms leverage plasmonic resonance for ultra-low detection limits, while lateral flow assays and imaging modules, including computed tomography, magnetic resonance imaging, photoacoustic modalities, electron microscopy, and optical imaging, are expanding clinical utility. In drug delivery, targeted chemotherapy carriers, gene delivery vectors, and protein delivery systems capitalize on precise surface conjugation chemistries to enhance therapeutic indices. Therapeutic applications harness photodynamic, photothermal, and radiotherapeutic mechanisms, translating nanoparticles’ photonic and radiative properties into patient-specific interventions.

Particle morphology plays a critical role in performance optimization. Cage, cube, prism, rod, shell, and spherical shapes each offer unique optical signatures and surface exposure, influencing cellular uptake and biodistribution. Size fractions spanning 0-20 nanometers, 20-50 nanometers, and above 50 nanometers are selected based on tissue penetration requirements and clearance profiles. Surface functionalities-antibody conjugation for selective targeting, polyethylene glycol for stealth properties, and thiol groups for stable ligand attachment-further refine nanoparticle behavior in biological systems.

End users range from academic research institutes pioneering foundational studies, biotechnology companies developing next-generation therapeutics, and cosmetics manufacturers exploring novel aesthetic formulations, to healthcare providers integrating diagnostic assays and pharmaceutical companies advancing clinical trials. Synthesis techniques, including chemical reduction, green synthesis approaches, and seed-mediated growth, underpin scalable production, quality control, and regulatory compliance. Together, these interwoven segments define the comprehensive landscape of gold nanoparticle innovation and adoption.

Regional Drivers and Barriers Shaping Global Gold Nanoparticle Adoption

Regional dynamics significantly influence the trajectory of gold nanoparticle adoption worldwide. In the Americas, advanced research institutions and leading pharmaceutical hubs foster an environment of rapid innovation and early commercialization. Robust funding ecosystems and established regulatory pathways encourage translational research, driving market uptake in both clinical and industrial domains.

In Europe, Middle East and Africa, regulatory harmonization efforts across major territories have lowered entry barriers, while investments in nanobiotechnology clusters have accelerated collaborative projects. Growing awareness of personalized medicine and point-of-care diagnostics is stimulating demand, even as emerging markets within this region seek cost-effective solutions tailored to local healthcare infrastructures.

The Asia-Pacific region has emerged as a manufacturing powerhouse, hosting large-scale production facilities for gold precursors and ligands. Significant public and private investment in nanoscience research has cultivated a vibrant innovation ecosystem. Rapidly expanding biotech sectors in key markets are adopting gold nanoparticle-enabled platforms, supported by favorable government incentives and streamlined approval processes. These regional drivers and barriers collectively shape the global competitive landscape, informing strategic decisions for stakeholders aiming to align with localized trends and opportunities.

Strategies of Leading Companies Redefining the Competitive Landscape

Leading organizations in the gold nanoparticle arena are executing multifaceted strategies to secure market leadership. Prominent material providers have intensified R&D investments to refine surface chemistries and scale green synthesis methods, targeting both research-grade and clinical-grade product lines. Specialized biotech firms are forging partnerships with academic laboratories and contract research organizations to co-develop application-specific formulations, accelerating bench-to-market timelines.

Component manufacturers are also diversifying their portfolios, integrating complementary nanomaterials such as quantum dots and polymeric carriers to offer turnkey solutions for multifunctional assays. Distribution networks are expanding through strategic alliances with global life science suppliers, ensuring broader market penetration and localized technical support. Concurrently, several companies are fortifying their intellectual property portfolios around proprietary synthesis protocols and functionalization platforms, establishing high barriers to entry and reinforcing competitive moats.

As regulatory scrutiny intensifies, market incumbents are proactively engaging with standards bodies to define best practices for characterization and safety assessment. This collective effort is driving convergence toward standardized metrics for size distribution, surface charge, and purity, which in turn fosters greater confidence among end users and accelerates regulatory approvals across multiple jurisdictions.

Practical Steps for Industry Leaders to Capitalize on Emerging Opportunities

To capture emerging opportunities, industry leaders should prioritize diversification of supply chains by establishing redundant manufacturing nodes and forging strategic alliances with raw material suppliers. Investing in modular production platforms that accommodate both chemical reduction and green synthesis methods will enable rapid scale-up and adaptive response to regulatory changes.

Collaborative research agreements with academic centers and clinical research organizations can accelerate validation pathways for novel applications, particularly in precision medicine and advanced diagnostics. Establishing cross-sector consortia to harmonize characterization standards will streamline regulatory submissions and minimize time-to-market. Additionally, pursuing alliances with digital technology providers to integrate artificial intelligence into functionalization workflows can optimize nanoparticle design, reducing experimental iterations and development costs.

Companies should also develop targeted go-to-market strategies that reflect regional nuances, tailoring product offerings to address specific healthcare challenges in Americas, Europe, Middle East and Africa, and Asia-Pacific markets. Embedding sustainability metrics into production processes will not only meet rising environmental standards but also resonate with investors and end users who prioritize eco-friendly innovations.

Rigorous Methodology Underpinning Our Insights

This research draws on a dual approach combining in-depth primary interviews with key executives, academic researchers, and regulatory authorities, alongside systematic secondary data collection from peer-reviewed journals, patent databases, trade publications, and official government reports. A rigorous triangulation process was implemented to validate insights and reconcile discrepancies among diverse information sources.

Quantitative data on production volumes, material costs, and regional trade flows were analyzed using statistical models to identify significant correlations and emerging trends. Qualitative analysis, including thematic coding of expert interviews, provided contextual understanding of innovation drivers and strategic priorities. All findings underwent multiple rounds of internal peer review, ensuring that conclusions are grounded in reliable evidence and reflect the most current industry developments.

Geopolitical scenarios, including tariff impacts and regulatory shifts, were stress-tested through sensitivity analyses to assess potential risks and mitigations. The resulting framework offers a robust, actionable foundation for stakeholders to navigate the complex gold nanoparticle ecosystem with confidence.

Concluding Perspectives on the Future Trajectory of Gold Nanoparticles

Gold nanoparticles stand at a pivotal juncture where technological advances and strategic imperatives converge to shape their future trajectory. Innovations in synthesis, functionalization, and application development are expanding the frontiers of possibility, while external factors such as tariffs and regional dynamics underscore the importance of resilient strategies.

The interplay of segmentation drivers-from application diversity to morphology, size, and surface chemistry-reveals a market characterized by nuanced requirements and high customization. Regional insights highlight the necessity of localized approaches, as growth rates and regulatory environments vary considerably across the Americas, Europe, Middle East and Africa, and Asia-Pacific.

Competitive analysis underscores that success will hinge on the ability to integrate cross-disciplinary expertise, align with evolving standards, and leverage strategic partnerships. By implementing the actionable recommendations outlined herein, organizations can position themselves at the vanguard of innovation, ready to capture the vast potential of gold nanoparticles in diagnostics, therapeutics, and beyond.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Diagnostics
      • Biosensing
      • Imaging
        • Computed Tomography
        • Magnetic Resonance Imaging
        • Photoacoustic Imaging
      • Lateral Flow Assays
    • Drug Delivery
      • Chemotherapy
      • Gene Delivery
      • Protein Delivery
    • Imaging
      • Electron Microscopy
      • Optical Imaging
    • Therapy
      • Photodynamic Therapy
      • Photothermal Therapy
      • Radiotherapy
  • Type
    • Cage
    • Cube
    • Prism
    • Rod
    • Shell
    • Spherical
  • Size
    • 0-20 nm
    • 20-50 nm
    • Above 50 nm
  • Surface Functionality
    • Antibody Conjugation
    • Polyethylene Glycol
    • Thiol
  • End User
    • Academic Research Institutes
    • Biotechnology Companies
    • Cosmetics Manufacturers
    • Healthcare Providers
    • Pharmaceutical Companies
  • Synthesis Method
    • Chemical Reduction
    • Green Synthesis
    • Seed Mediated Growth
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • nanoComposix, Inc.
  • BBI Solutions Ltd.
  • Cytodiagnostics Inc.
  • Nanocs, Inc.
  • Ted Pella, Inc.
  • NanoHybrids, LLC
  • Nanopartz, LLC
  • British BioCell International Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Gold Nanoparticle Market, by Application
8.1. Introduction
8.2. Diagnostics
8.2.1. Biosensing
8.2.2. Imaging
8.2.2.1. Computed Tomography
8.2.2.2. Magnetic Resonance Imaging
8.2.2.3. Photoacoustic Imaging
8.2.3. Lateral Flow Assays
8.3. Drug Delivery
8.3.1. Chemotherapy
8.3.2. Gene Delivery
8.3.3. Protein Delivery
8.4. Imaging
8.4.1. Electron Microscopy
8.4.2. Optical Imaging
8.5. Therapy
8.5.1. Photodynamic Therapy
8.5.2. Photothermal Therapy
8.5.3. Radiotherapy
9. Gold Nanoparticle Market, by Type
9.1. Introduction
9.2. Cage
9.3. Cube
9.4. Prism
9.5. Rod
9.6. Shell
9.7. Spherical
10. Gold Nanoparticle Market, by Size
10.1. Introduction
10.2. 0-20 nm
10.3. 20-50 nm
10.4. Above 50 nm
11. Gold Nanoparticle Market, by Surface Functionality
11.1. Introduction
11.2. Antibody Conjugation
11.3. Polyethylene Glycol
11.4. Thiol
12. Gold Nanoparticle Market, by End User
12.1. Introduction
12.2. Academic Research Institutes
12.3. Biotechnology Companies
12.4. Cosmetics Manufacturers
12.5. Healthcare Providers
12.6. Pharmaceutical Companies
13. Gold Nanoparticle Market, by Synthesis Method
13.1. Introduction
13.2. Chemical Reduction
13.3. Green Synthesis
13.4. Seed Mediated Growth
14. Americas Gold Nanoparticle Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Gold Nanoparticle Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Gold Nanoparticle Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Merck KGaA
17.3.2. Thermo Fisher Scientific Inc.
17.3.3. nanoComposix, Inc.
17.3.4. BBI Solutions Ltd.
17.3.5. Cytodiagnostics Inc.
17.3.6. Nanocs, Inc.
17.3.7. Ted Pella, Inc.
17.3.8. NanoHybrids, LLC
17.3.9. Nanopartz, LLC
17.3.10. British BioCell International Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. GOLD NANOPARTICLE MARKET MULTI-CURRENCY
FIGURE 2. GOLD NANOPARTICLE MARKET MULTI-LANGUAGE
FIGURE 3. GOLD NANOPARTICLE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL GOLD NANOPARTICLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2024 VS 2030 (%)
FIGURE 18. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS GOLD NANOPARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS GOLD NANOPARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES GOLD NANOPARTICLE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES GOLD NANOPARTICLE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GOLD NANOPARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GOLD NANOPARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC GOLD NANOPARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC GOLD NANOPARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. GOLD NANOPARTICLE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. GOLD NANOPARTICLE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. GOLD NANOPARTICLE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GOLD NANOPARTICLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY BIOSENSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY PHOTOACOUSTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY GENE DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY PROTEIN DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY ELECTRON MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY PHOTODYNAMIC THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY PHOTOTHERMAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY CAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY CUBE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY PRISM, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY ROD, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY SHELL, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY SPHERICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY 0-20 NM, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY 20-50 NM, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY ABOVE 50 NM, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY ANTIBODY CONJUGATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY POLYETHYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY THIOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY COSMETICS MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY CHEMICAL REDUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY GREEN SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL GOLD NANOPARTICLE MARKET SIZE, BY SEED MEDIATED GROWTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS GOLD NANOPARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES GOLD NANOPARTICLE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 79. CANADA GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. CANADA GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 81. CANADA GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 82. CANADA GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 83. CANADA GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 84. CANADA GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 85. CANADA GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. CANADA GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 87. CANADA GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 88. CANADA GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. CANADA GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 90. MEXICO GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. MEXICO GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 92. MEXICO GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 93. MEXICO GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 94. MEXICO GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 95. MEXICO GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 96. MEXICO GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. MEXICO GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 98. MEXICO GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 99. MEXICO GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. MEXICO GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA GOLD NANOPARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 146. GERMANY GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. GERMANY GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 148. GERMANY GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 149. GERMANY GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 150. GERMANY GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 151. GERMANY GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 152. GERMANY GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. GERMANY GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 154. GERMANY GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 155. GERMANY GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. GERMANY GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 157. FRANCE GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. FRANCE GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 159. FRANCE GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 160. FRANCE GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 161. FRANCE GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 162. FRANCE GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 163. FRANCE GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. FRANCE GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 165. FRANCE GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 166. FRANCE GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. FRANCE GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 179. ITALY GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. ITALY GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 181. ITALY GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 182. ITALY GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 183. ITALY GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 184. ITALY GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 185. ITALY GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 186. ITALY GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 187. ITALY GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 188. ITALY GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. ITALY GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 190. SPAIN GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. SPAIN GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 192. SPAIN GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 193. SPAIN GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 194. SPAIN GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 195. SPAIN GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 196. SPAIN GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 197. SPAIN GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 198. SPAIN GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 199. SPAIN GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. SPAIN GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 214. SAUDI ARABIA GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 216. SAUDI ARABIA GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 217. SAUDI ARABIA GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 218. SAUDI ARABIA GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 219. SAUDI ARABIA GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 220. SAUDI ARABIA GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. SAUDI ARABIA GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 226. SOUTH AFRICA GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 228. SOUTH AFRICA GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 229. SOUTH AFRICA GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 230. SOUTH AFRICA GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 231. SOUTH AFRICA GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 232. SOUTH AFRICA GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. SOUTH AFRICA GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 234. DENMARK GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. DENMARK GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 236. DENMARK GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 237. DENMARK GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 238. DENMARK GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 239. DENMARK GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 240. DENMARK GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 241. DENMARK GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 242. DENMARK GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 243. DENMARK GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. DENMARK GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. NETHERLANDS GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 247. NETHERLANDS GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 248. NETHERLANDS GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 249. NETHERLANDS GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 250. NETHERLANDS GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 251. NETHERLANDS GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 252. NETHERLANDS GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 253. NETHERLANDS GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 254. NETHERLANDS GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. NETHERLANDS GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 256. QATAR GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. QATAR GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 258. QATAR GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 259. QATAR GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 260. QATAR GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 261. QATAR GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 262. QATAR GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 263. QATAR GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 264. QATAR GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 265. QATAR GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. QATAR GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 267. FINLAND GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. FINLAND GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 269. FINLAND GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 270. FINLAND GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 271. FINLAND GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 272. FINLAND GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 273. FINLAND GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 274. FINLAND GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 275. FINLAND GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 276. FINLAND GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. FINLAND GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. SWEDEN GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 280. SWEDEN GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 281. SWEDEN GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 282. SWEDEN GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 283. SWEDEN GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 284. SWEDEN GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 285. SWEDEN GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 286. SWEDEN GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 287. SWEDEN GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. SWEDEN GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 289. NIGERIA GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. NIGERIA GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 291. NIGERIA GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 292. NIGERIA GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 293. NIGERIA GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 294. NIGERIA GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 295. NIGERIA GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 296. NIGERIA GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 297. NIGERIA GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 298. NIGERIA GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. NIGERIA GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 300. EGYPT GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. EGYPT GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 302. EGYPT GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 303. EGYPT GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 304. EGYPT GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 305. EGYPT GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 306. EGYPT GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 307. EGYPT GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 308. EGYPT GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 309. EGYPT GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. EGYPT GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 311. TURKEY GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 312. TURKEY GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 313. TURKEY GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 314. TURKEY GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 315. TURKEY GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 316. TURKEY GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 317. TURKEY GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 318. TURKEY GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 319. TURKEY GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 320. TURKEY GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 321. TURKEY GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 322. ISRAEL GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 323. ISRAEL GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 324. ISRAEL GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 325. ISRAEL GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 326. ISRAEL GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 327. ISRAEL GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 328. ISRAEL GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 329. ISRAEL GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 330. ISRAEL GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 331. ISRAEL GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 332. ISRAEL GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 333. NORWAY GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 334. NORWAY GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 335. NORWAY GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 336. NORWAY GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 337. NORWAY GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 338. NORWAY GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 339. NORWAY GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 340. NORWAY GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 341. NORWAY GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 342. NORWAY GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 343. NORWAY GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 344. POLAND GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 345. POLAND GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 346. POLAND GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 347. POLAND GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 348. POLAND GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 349. POLAND GOLD NANOPARTICLE MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 350. POLAND GOLD NANOPARTICLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 351. POLAND GOLD NANOPARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
TABLE 352. POLAND GOLD NANOPARTICLE MARKET SIZE, BY SURFACE FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 353. POLAND GOLD NANOPARTICLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 354. POLAND GOLD NANOPARTICLE MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 355. SWITZERLAND GOLD NANOPARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 356. SWITZERLAND GOLD NANOPARTICLE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 357. SWITZERLAND GOLD NANOPARTICLE MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 358. SWITZERLAND GOLD NANOPARTICLE MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 359. SWITZERLAND GOLD NANOPARTICLE MARKET SIZE, BY

Samples

Sample File DOWNLOAD NOW

Companies Mentioned

The companies profiled in this Gold Nanoparticle market report include:
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • nanoComposix, Inc.
  • BBI Solutions Ltd.
  • Cytodiagnostics Inc.
  • Nanocs, Inc.
  • Ted Pella, Inc.
  • NanoHybrids, LLC
  • Nanopartz, LLC
  • British BioCell International Ltd.

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 888.15 Million
Forecasted Market Value ( USD ) by 2030 $ 1450 Million
Compound Annual Growth Rate10.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Gold Nanoparticles - Global Strategic Business Report - Product Image

Gold Nanoparticles - Global Strategic Business Report

  • Report
  • 260 Pages
  • Global
From
EUR$5,850USDGBP
Gold Nanoparticles Market by Process (Physical, Chemical, Biological), Application (Imaging, Targeted Drug Delivery, Proton Therapy, in-Vitro Assays, Sensors, Probes, Catalysis), End-Use Industry and Region - Global Forecast to 2029 - Product Image

Gold Nanoparticles Market by Process (Physical, Chemical, Biological), Application (Imaging, Targeted Drug Delivery, Proton Therapy, in-Vitro Assays, Sensors, Probes, Catalysis), End-Use Industry and Region - Global Forecast to 2029

  • Report
  • 240 Pages
  • Global
From
EUR$4,950USDGBP
Gold Nanoparticles Market Report by Type (Water Soluble, Oil Soluble, and Others), Application (Imaging, Targeted Drug Delivery, Sensors, in Vitro Diagnostics, Probes, Catalysis, and Others), End-Use Industry (Electronics, Healthcare, Chemicals, and Others), and Region 2025-2033 - Product Image

Gold Nanoparticles Market Report by Type (Water Soluble, Oil Soluble, and Others), Application (Imaging, Targeted Drug Delivery, Sensors, in Vitro Diagnostics, Probes, Catalysis, and Others), End-Use Industry (Electronics, Healthcare, Chemicals, and Others), and Region 2025-2033

  • Report
  • 148 Pages
  • Global
From
EUR$2,999USDGBP
Superparamagnetic Iron Oxide Nanoparticles Market by Application, Product Type, Coating Type, End User, Synthesis Method, Form, Functionalization Type - Global Forecast to 2030 - Product Image

Superparamagnetic Iron Oxide Nanoparticles Market by Application, Product Type, Coating Type, End User, Synthesis Method, Form, Functionalization Type - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Magnetite Nanoparticles Market by Application, Type, Synthesis Method, Particle Size, Surface Functionalization - Global Forecast to 2030 - Product Image

Magnetite Nanoparticles Market by Application, Type, Synthesis Method, Particle Size, Surface Functionalization - Global Forecast to 2030

  • Report
  • 197 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Copyright © 2002-2025 Research and Markets. All Rights Reserved.
This website uses cookies to ensure you get the best experience. Learn more